Mar 08, 2023
1:20
For every 20 shares held, investors received 1. The price per share adjusted from $12.58 to $251.52.
The split itself did not change the total investment value.
Carisma Therapeutics, Inc. (OTC:CARM) operates in the Biotechnology industry.
Carisma Therapeutics, Inc. company overviewCarisma Therapeutics, Inc.'s most recent stock split was on March 8, 2023. It was a 1-for-20 reverse split, so shareholders received 1 share for every 20 they held.
Carisma Therapeutics, Inc. has split its stock once. This history records one reverse split, on March 8, 2023.
A reverse stock split combines several shares into one and raises the price per share by the same factor, so the total value of a holding does not change. In Carisma Therapeutics, Inc.'s 1-for-20 reverse split on March 8, 2023, every 20 shares became one share. Companies often use reverse splits to lift a low share price, for example to keep meeting an exchange's minimum price requirement.
Carisma Therapeutics, Inc. has not announced a new split in our records. Its most recent split was on March 8, 2023, 3 years ago. Companies announce splits in advance, and any new OTC:CARM split will appear on this page.